A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Summary

The purpose of this study is to evaluate the efficacy of deucravacitinib versus placebo at Week 24 and safety and tolerability of deucravacitinib versus placebo in adults with alopecia areata.

Timeline

Start

2022-11-08

Primary completion

2024-01-06

Completion

2024-05-16

Outcome

Outcome not reported

Stopped (Business): “Business objectives have changed”

Drugs

Indications